Doxorubicin Loaded Liposomal Nanoparticles Containing Quantum Dot for Treatment of Breast Cancer

Document Type : Research Article


1 Department of Chemical Engineering, Tehran Science and Research Branch, Islamic Azad University, Tehran, I.R. IRAN

2 Department of Nanobiotechnology, Pasteur Institute of Iran, Tehran, I.R. IRAN

3 Department of Chemical Engineering, South Tehran Branch, Islamic Azad University, Tehran, I.R. IRAN


In addition to increasing the efficacy of various drugs, Nanoparticles reduce their side effects. In this study, different nanoparticle formulations of Doxorubicin anticancer drugs were prepared. The efficacy of the formulations produced in the cell culture medium was studied compared with the free drug. Reverse phase evaporation was used to form the liposome containing doxorubicin. The graphite nanoparticles were prepared. These nanoparticles were mixed with the liposome containing doxorubicin, and the related Nano-complex was conjugated. Spectroscopy methods for visible light-ultraviolet, light and light dynamics differentiation were used to describe nanoparticles. For the toxicity of different formulation, MTT and MCF-7 cells were used. The amount of drug loading in the liposomes was 72%. The largest amount was related to the Nano-conjugated complex and the smallest size was related to the graphene-oxide nanoparticle with a nanometer size. The controlled release in 96 hours and the amount of drug release was 95.43%. Doxorubicin-containing liposome toxicity was 75% and Nano- conjugated complex was 85%, at the lowest drug concentration (10µM). The free drug created 35% cell toxicity in 10µM and 89% in 2500µM. The results of the study showed Liposomes act as a suitable nanoparticle for doxorubicin. It was found that the effect of nanoparticles of graphene oxide is very important. In the presence of this nanoparticle in the complex, toxicity increased significantly.


Main Subjects

[1] Alavi S.E., Koohi Moftakhari Esfahani M., Alavi F., Movahedi F., Akbarzadeh A., Drug Delivery of Hydroxyurea to Breast Cancer Using Liposomes, Ind J Clin Biochem, 19(2): 12-29 (2012).
[3] Behroozeh A., Mazloumi Tabrizi M., Kazemi S.M., Choupani E., Kabiri N., Ilbeigi D., Heydari Nasab A., Akbarzadeh Khiyavi A., Seif Kurdi A., Evaluation the Anti-Cancer Effect of PEGylated Nano-Niosomal Gingerol, on Breast Cancer Cell lines (T47D), In-Vitro. APJCP, 19(3):645-648 (2018).
[4] Burda C., Chen X., Narayanan R., El-Sayed M.A., Chemistry and Properties of Nanocrystals of Different Shapes, Chem Rev, 105(4):1025–102 (2005).
[5] Coradeghini R., Gioria S., García C.P., Nativo P., Franchini F., Gilliland D., Ponti J., Rossi F., Size-de-Pendent Toxicity and Cell Interaction Mechanisms of Gold Nanoparticles on Mouse Fibroblasts, Toxicol Lett, 217(3): 205-16 (2013).
[8] Devika B., Chithrani, Michael Dunne, BASc, James Stewart, MASc, Christine Allen, David A.  Jaffray. Cellular Uptake and transport of Gold Nanoparticles Incorporated in a Liposomal Carrier. Nanomedicine: Nanotechnology, Biology, and Medicine, 6(1): 161–169 (2017).
[9] Farahnak Zarabi M., Farhangi A., Khademi Mazdeh S., Ansarian Z., Zare D., Mehrabi M.R., Akbarzadeh A., Synthesis of Gold Nanoparticles Coated with Aspartic Acid and Their Conjugation with FVIII Protein and FVIII Antibody, Ind J Clin Bio-chem. 2013; doi: 10.1007/s12291-013-0323-2.
[11] Heidary Alizadeh B., Vosooghi M., Khoobi M., Javidnia A.,; Foroumadi A., Panah F., Safavi M., Ardestani S., Shafiee A., Synthesis and Cytotoxic Activity of Novel 9-[Hydroxy(Substitutedphenyl) Methyl]-2,2- Dimethyl-2,3,8,9-Tetrahydro-4H,10H-Pyrano [2,3-f] Chromene-4,10-Diones, Iranian Journal of Chemistry and Chemical Engineering (IJCCE), 29(4): 189-196 (2010). 
[13] Immordino M.L., Dosio F., Cattel L., Stealth Liposomes: Review of the Basic Science, Rationale, and Clinical Applications, Existing and Potential, Int J Nanomed, 1(3): 297–315 (2016).
[14] Jung T., Kamm W., Breitenbach A., Kaiserling E., Xiao J.X., Kissel T., Biodegradable Nanoparticles for Oral Delivery of Peptides: is There a Role for Polymers to Affect Mucosal Uptake?, Eur. J. Pharm. Biopharm50: 147-60 (2012).
[15] Kanaani L., Mazloumi Tabrizi M., Akbarzadeh A., Javadi I., Improvement the Efficacy of Cisplatin by Niosome Nanoparticles against Human Breast Cancer Cell Line BT-20: An in Vitro Study, APJCB, 2(2): 25-26 (2017).
[16] Kojima C., Hirano Y., Kono K., Chapter 7 - Preparation of Complexes of Liposomes with Gold Nanoparticles, Methods Enzymol, 464: 131-145 (2009).
[17] Liebelt E.L., Balk S.J., Faber W., Fisher J.W., Hughes C.L., Lanzkron S.M., Lewis K.M., Marchetti F., Mehendale H.M., Rogers J.M., Shad A.T., Skalko R.G., Stanek E.J., NTP-CERHR Expert Panel Report on the Reproductive and Developmental Toxicity of Hydroxyurea., 80(4): 259-366 (2007).
[19] Mahmoud Mady M., Mahmoud Fathy M., Youssef T., Mohamed Khalil W., Biophysical Characterization of Gold Nanoparticles-Loaded Liposomes, Physica Medica, 28(4): 288-295 (2012).
[22] Mozafari M.R., Nanocarrier Technologies, Frontiers of Nanotherapy, 237(5): 1-12 (2006).
[23] Nimesh S., Manchanda R., Kumar R., Saxena A., Chaudhary P., Yadav V., Mozumdar S., Chandra R., Preparation, Characterization and in Vitro Drug Release Studies of Novel Polymeric Nanoparticles,  Int. J. Pharm., 323(1-2): 146-152 (2006).
[24] Paasonen L., Laaksonen T., Johans C., Yliperttula M., Konttun K., Urtti A., Gold Nanoparticles Enable Selective Light-Induced Contents Release from Liposomes, J. Control Release, 122(1): 86–93 (2007).
[25] Paolino D., Fresta M., Sinha P., Ferrari M., “Drug Delivery Systems”, In: Webester J.G., (Editor). “Encyclo-Pedia of Medical Devices and Instrumentation”, 2nd ed. John Wiley and Sons, Inc., 437-495 (2006).
[27] Soppimath K., Aminabhavi T.M., Kulkarni A.R., Rudzinski W.E., Biodegradable Polymeric Nanopar-Ticles as Drug Delivery Devices, J. Controlled Release, 70 (1-2): 1-20 (2001).
[29] Volodkin D.V., Skirtach A.G., Mohwald H., Near-IR Remote Release from Assemblies of Liposomes and Nanoparticles, Angew. Chem. Int. Ed. Engl., 48(10): 1807–1809 (2009).
[30] Wang X., Yang L., Chen Z.(Georgia), Dong M. Shin., Application of Nanotechnology in Cancer Therapy and Imaging, CA Cancer J. Clin., 58(2): 97-110 (2008).
[32] Wu G., Mikhailovsky A., Khant H.A., Fu C., Chiu W., Zasadzinski J.A., Remotely Triggered Liposome Release by Near-Infrared Light Absorption via Hollow Gold Nanoshells, J. Am. Chem. Soc.,118(2) 130- 139   (2008).